KEY POINT SUMMARY โ Musk Blindness
โข Musk Blindness mission advances with new Neuralink brain chip
โข First human trial to restore sight planned for late 2025
โข Animal testing shows the chip can help blind subjects regain vision
โข Neuralink filed trademarks for โBlindsight,โ โtelepathy,โ and โtelekinesis.โ
โข Full rollout will follow further testing and regulatory approval
Musk Blindness Mission Takes Major Step Forward
Elon Musk has revealed plans for a groundbreaking medical trial later this year. His brain tech company Neuralink, will implant its first sight-restoring chip, Blindsight, in a human.
The goal is clear. The chip will help those with complete blindness regain partial vision, marking a milestone for Muskโs ambitious Blindness initiative.
Neuralinkโs Animal Trials Show Success
During a public event in Wisconsin, Musk detailed the chipโs progress. Tests on monkeys proved successful. He said the animals remain healthy after implantation.
โThe first human test will offer low-resolution sight,โ Musk admitted. โBut eventually, vision could become superhuman.โ
His remarks confirm what many speculated โ that Muskโs Blindness solutions are advancing faster than expected.
Blindsight Trademarked As Neuralink Expands Ambitions
In recent weeks, Neuralink secured trademarks for โBlindsight,โ โtelepathy,โ and โtelekinesis.โ These terms hint at the companyโs far-reaching vision for human-computer interaction.
But for now, Musk Blindness efforts remain focused on restoring vision to those who need it most.
Neuralink Celebrates Earlier Success In Restoring Movement
Earlier in 2024, Neuralinkโs implants helped patients with paralysis regain control over their limbs. Those trials marked the companyโs first human success stories.
โFeedback from participants is invaluable,โ Neuralink shared in a blog post. โIt helps us refine designs and better meet usersโ needs.โ
Timeline For Widespread Use Still Unclear
Although Muskโs team is optimistic, the broader release of the Musk Blindness solution is still in the future. Regulatory approval and further tests are needed.
However, Musk believes the journey has begun. With human trials set for late 2025, hopes are high that Neuralink could soon help millions.